Yoshitaka Imamichi

Yoshitaka Imamichi

Auto-generated profile, based on publicly available information

Yoshitaka Imamichi

Dept. Pharmacol., Asahikawa Med. Univ

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
TYTakashi Yazawa
Takashi Yazawa
YIYoshitaka Imamichi
Yoshitaka Imamichi
TSToshio Sekiguchi
Toshio Sekiguchi
KMKaoru Miyamoto
Kaoru Miyamoto
JUJunsuke Uwada
Junsuke Uwada
TTTakanobu Taniguchi
Takanobu Taniguchi
Ovaries represent one of the primary steroidogenic organs, producing estrogen and progesterone under the regulation of gonadotropins during the estrous cycle. Gonadotropins fluctuate the expression of various steroidogenesis-related genes, such as those encoding steroidogenic enzymes, cholesterol deliverer, and electronic transporter. Steroidogenic factor-1 (SF-1)/adrenal 4-binding protein (Ad4BP)/NR5A1 and liver receptor homolog-1 (LRH-1) play important roles in these phenomena via transcriptional regulation. With the aid of cAMP, SF-1/Ad4BP and LRH-1 can induce the differentiation of stem cells into steroidogenic cells. This model is a useful tool for studying the molecular mechanisms of steroidogenesis. In this article, we will provide insight into the transcriptional regulation of steroidogenesis-related genes in ovaries that are revealed from stem cell-derived steroidogenic cells. Using the cells derived from the model, novel SF-1/Ad4BP- and LRH-1-regulated genes were identified by combined DNA microarray and promoter tiling array analyses. The interaction of SF-1/Ad4BP and LRH-1 with transcriptional regulators in the regulation of ovarian steroidogenesis was also revealed.

1 January 2020 in Proceedings for Annual Meeting of The Japanese Pharmacological Society
Verified
Journal Article
Open access
PDF file
KYKoh-Ichi Yuhki
Koh-Ichi Yuhki
THTomohiro Hirata
Tomohiro Hirata
YIYoshitaka Imamichi
Yoshitaka Imamichi
HKHitoshi Kashiwagi
Hitoshi Kashiwagi
SNShuh Narumiya
Shuh Narumiya
FUFumitaka Ushikubi
Fumitaka Ushikubi
Inflammatory cytokines, such as interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha, are the major priming factors in liver regeneration facilitating the G1-phase transition of hepatocytes. Previously, we showed that prostaglandin (PG) I2 stimulates the expression of IL-6 mRNA via its receptor IP in the remnant liver of mice after 70% partial hepatectomy. The relation between PGI2 and TNF-alpha, however, remains undetermined. Therefore, we examined the relation using primary cultured Kupffer cells and hepatocytes. Kupffer cells were stimulated with TNF-alpha for 30 minutes. TNF-alpha up-regulated the expression level of IL-6 mRNA in cultured wild-type (WT) Kupffer cells. Interestingly, IP agonist significantly increased the TNF-alpha induced up-regulation of IL-6 mRNA, and this accelerative effect of IP agonist disappeared in IP–/– Kupffer cells. We next stimulated cultured hepatocytes with TNF-alpha for 72 hours. After 72 hours, the expression level of IP mRNA increased significantly compared with that in vehicle treatment. We next examined whether IP activation can induce phosphorylation of cAMP-regulatory element binding protein (CREB) in the TNF-alpha stimulated hepatocytes using the Western blot assay, because IP belongs to a Gs-coupled receptor family, and CREB phosphorylation stimulates hepatocyte proliferation. Indeed, IP agonist induced the phosphorylation of CREB, which effect disappeared in vehicle treated WT hepatocytes. These results suggest that PGI2 facilitates liver regeneration in cooperation with TNF-alpha.